The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126184531 12618453 1 I 20110101 0 20160802 20160802 DIR 56.00 YR F N 0.00000 20160801 N OT US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126184531 12618453 1 PS GLEEVEC IMATINIB MESYLATE 1 0 400 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126184531 12618453 1 Chronic myeloid leukaemia

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126184531 12618453 Diarrhoea
126184531 12618453 Eye oedema
126184531 12618453 Muscle spasms
126184531 12618453 Oedema
126184531 12618453 Oedema peripheral

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID CASEID RPSR COD
126184531 12618453 HP

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126184531 12618453 1 20110101 20160801 0